Re: GNVC I'm going to keep my mouth shut until the data are out at ASCO. It's probably the prudent thing to do ;-) On another note, it appears that a long time borderline program, phenoxodiol, is about to come to an end: Pivotal trial stopped at ~1/3rd enrollment: <a href="http://www.novogen.com/news/news0501.cfm?mainsection=05&subsection=01&newsid=320" rel="nofollow" target="_blank">http://www.novogen.com/news/news0501.cfm?mainsection=05&subsection=01&newsid=320</a> From the former CEO / Chairman: <a href="http://www.kellymusings.com/ovature.php" rel="nofollow" target="_blank">http://www.kellymusings.com/ovature.php</a>